One Nucleus announces finalists of the BioNewsRound Award

28th November 2019

London, UK, 28th November 2019 / Sciad NewswireOne Nucleus reveals the finalists of its annual BioNewsRound Award, recognising life science companies that have announced exciting developments for patients and the sector. The finalists will present at Genesis 2019 where the winner will be announced. 

Companies were nominated for their most important news stories from the last year. These were assessed based on their impact on the organisation, whether they demonstrated an exciting development in the life sciences sector and whether they have the potential to significantly benefit patients. This year’s nominations were particularly competitive, with 45 news stories submitted. The finalists are listed below:

  • Arctoris – Arctoris Ltd Secures Seed Funding of £3.2 Million to Advance Novel Drug Discovery Platform Powered by Robotics
  • Astex Therapeutics – Astex Pharmaceuticals Celebrates as Second New Cancer Drug Receives US Marketing Approval
  • AstraZeneca – AstraZeneca and Daiichi Sankyo enter collaboration for novel HER2-targeting antibody-drug conjugate
  • Domainex – Potential new treatment for heart attack: Prospective drug found by testing in human heart muscle grown from stem cells 
  • Guy’s and St Thomas’ NHS Foundation Trust – Innovative device to remove blood clots used in patient for first time
  • Healx – Healx secures $56m in Series B financing, launches global accelerator programme for rare diseases
  • Oncimmune – Ground-breaking trial demonstrates potential of blood test which harnesses the power of the immune system to reduce late detection of lung cancer

The winner will be announced at the culmination of the prestigious annual Genesis conference in London on 11th December where each finalist will present their story and all conference delegates will vote. Now in its 19th year, Genesis will cover the impact of recent scientific, technological and investment trends and advances on the Life Science and Healthcare Industry. 70 expert speakers are already confirmed, spread across plenary talks, panel discussions and four key streams; understanding deal makers, nurturing digital health champions, redefining therapeutic areas, and meeting biotech rising stars.

Register to attend Genesis 2019 to learn more about the award finalists alongside other exciting developments in life sciences and healthcare.

Ends

For further information, contact:

One Nucleus
Laura Hicks
Email: info@onenucleus.com
Tel: +44 (0)1223 896450

Sciad Communications Ltd
Victoria Deaner 
E: victoria@sciad.com
T: +44 (0)20 3755 0571

Notes to Editors

About One Nucleus

Established in 1997, One Nucleus is an award winning not-for-profit Life Sciences & Healthcare membership organisation centred on the Greater London-Cambridge-East of England corridor. Headquartered in Cambridge, at the heart of Europe’s largest Life Sciences & Healthcare cluster, we support those institutions, companies and individuals undertaking activity in or with the above region.

Through providing the local, UK-wide and international connectivity, One Nucleus seeks to enable our members to maximise their performance. This support helping them achieve, or better still exceed, the goals they have set for themselves. Biomedical and Healthcare R&D have always been impactful in driving social and economic progress. In an increasingly outsourced, collaborative and multi-disciplinary sector, bringing the best people together is key to translating great innovation into great products that markedly improve patient outcomes and drive economic development. Attracting and enabling the best people to engage with is at the heart of the One Nucleus team ethos and what we continually strive to deliver.